Pages that link to "Q37105532"
Jump to navigation
Jump to search
The following pages link to Epidemiology and surveillance of hepatocellular carcinoma (Q37105532):
Displaying 50 items.
- Alcohol and Viral Hepatitis: Role of Lipid Rafts (Q26773213) (← links)
- Strategies to increase the resectability of hepatocellular carcinoma (Q26795530) (← links)
- Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data (Q31048824) (← links)
- Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection (Q33621633) (← links)
- A carbohydrate-grafted nanovesicle with activatable optical and acoustic contrasts for dual modality high performance tumor imaging (Q33869355) (← links)
- Familial correlations of onset age of hepatocellular carcinoma: a population-based case-control family study (Q34233259) (← links)
- Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo (Q34402163) (← links)
- Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma (Q34696921) (← links)
- Hepatocellular carcinoma in Asia: Prevention strategy and planning (Q35790424) (← links)
- Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma. (Q35864817) (← links)
- Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials (Q36046058) (← links)
- Does Pay-For-Performance Program Increase Providers Adherence to Guidelines for Managing Hepatitis B and Hepatitis C Virus Infection in Taiwan? (Q36102532) (← links)
- Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease (Q36181189) (← links)
- Targeted DNA and RNA sequencing of fine-needle biopsy FFPE specimens in patients with unresectable hepatocellular carcinoma treated with sorafenib (Q36356419) (← links)
- Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma (Q36423170) (← links)
- Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States (Q36540044) (← links)
- Hypermethylation and Expression Silencing of PDCD4 Gene in Hepatocellular Carcinoma: A Consort Study (Q36580984) (← links)
- Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection. (Q36905681) (← links)
- Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma (Q37031706) (← links)
- The Effectiveness of ART Score in Selecting Patients for Transarterial Chemoembolization Retreatment: A Cohort Study in Taiwan. (Q37328442) (← links)
- Hepatocellular Carcinoma and Its Precursors in 103 HBV-Related Cirrhotic Explanted Livers: A Study from South Iran (Q37350820) (← links)
- Erlotinib for advanced hepatocellular carcinoma. A systematic review of phase II/III clinical trials (Q37637658) (← links)
- Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy (Q37716237) (← links)
- Hepatocellular carcinoma with obstructive jaundice: endoscopic and percutaneous biliary drainage (Q38069065) (← links)
- Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging (Q38083432) (← links)
- Recent advancements in comprehensive genetic analyses for human hepatocellular carcinoma (Q38083435) (← links)
- The NQO1 C609T polymorphism and hepatocellular carcinoma risk (Q38188524) (← links)
- A clinical perspective on the role of chronic inflammation in gastrointestinal cancer (Q38241837) (← links)
- Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis (Q38366584) (← links)
- Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature (Q38793776) (← links)
- Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study (Q38939495) (← links)
- Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database. (Q38948642) (← links)
- Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma (Q38974538) (← links)
- Cold-inducible RNA-binding protein promotes the development of liver cancer (Q39959260) (← links)
- Circulating Hypermethylated RASSF1A as a Molecular Biomarker for Diagnosis of Hepatocellular Carcinoma (Q40149759) (← links)
- Assessment of Lipiodol Deposition and Residual Cancer for Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization via Iodine-Based Material Decomposition Images with Spectral Computed Tomography Imaging: A Preliminary Study (Q40159677) (← links)
- Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients (Q40330653) (← links)
- Lack of Any Relationship Between Circulating Autoantibodies and Interleukin–6 Levels in Egyptian Patients Infected with the Hepatitis C Virus (Q40391710) (← links)
- Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients (Q40572955) (← links)
- TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice (Q41646089) (← links)
- Long non-coding RNA AB209630 suppresses cell proliferation and metastasis in human hepatocellular carcinoma (Q42376378) (← links)
- Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma (Q45728871) (← links)
- Anti-IL-20 monoclonal antibody inhibited tumor growth in hepatocellular carcinoma (Q47099804) (← links)
- Cost-effectiveness analysis of treatments involving radioembolization in intermediate-stage hepatocellular carcinoma. (Q47325384) (← links)
- Should AFP (or any biomarkers) be used for HCC surveillance? (Q50223186) (← links)
- Novel therapeutic modalities and drug delivery - erlotinib liposomes modified with galactosylated lipid: in vitro and in vivo investigations (Q50224629) (← links)
- Real-life clinical practice with sorafenib in advanced hepatocellular carcinoma: a single-center experience (Q51288634) (← links)
- Gender differences in the livers of patients with hepatocellular carcinoma and chronic hepatitis C infection (Q51286887) (← links)
- Quantification of tumor DNA in serum and vascular invasion of human hepatocellular carcinoma. (Q54270867) (← links)
- Risk of Hepatocellular Carcinoma Development in Cases of Hepatitis C Treated by Long-Term, Low-Dose PEG-IFNa-2a (Q57763153) (← links)